-+ 0.00%
-+ 0.00%
-+ 0.00%

Guggenheim Reiterates Buy on Century Therapeuticsto Buy

Benzinga·03/28/2025 14:43:23
Listen to the news
Guggenheim analyst Kelsey Goodwin reiterates Century Therapeutics (NASDAQ:IPSC) from Buy to Buy.